Clinical Trial

Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment

Study acronym: LOSTIT
Recruiting
View on ClinicalTrials.gov →
Summary
A growing body of evidence suggests patients with late-onset seizures are at an increased risk of stroke, but the potential for reducing cardiovascular morbidity through risk factor screening and management is unknown. The investigators aim to determine whether individuals with new-onset unprovoked seizures after middle age should undergo vascular risk assessment. In a cluster project the investigators assess the effect of vascular risk factor screening in an observational study as well as a cohort study. The project has two interlinked components: a prospective single group study, in which risk factor assessment is performed and subsequent management is followed for one year; and a register-based cohort study examining the long-term effects of the intervention on a system level.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-08.
Status change: Not Yet Recruiting → Recruiting 2026-02-27
Trial Details
NCT Number NCT07116330
Lead Sponsor Sahlgrenska University Hospital
Collaborators: Sodra Alvsborgs Hospital, Skane University Hospital, Danderyd Hospital, Uppsala University Hospital
Conditions Epilepsy, Seizure
Enrollment 420 participants
Start Date 2025-09-01
Primary Completion 2027-12 (estimated)
Study Completion 2035-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-03